Search

everythinglearnresearchcommunity

for

Search:↓

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Early physiotherapy with exercises and stretching is crucial for treating congenital torticollis.

VSELs may hold the key to longer life through regenerative therapies.

Probiotics with Lactobacillus reuteri improve IBS symptoms in children.

NF-κB is crucial for zebrafish heart repair, affecting heart cell growth and repair processes.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Puerariae Lobatae Radix can reduce sebaceous gland size and secretion, potentially treating related skin conditions.

Upadacitinib effectively treats psoriasis and lichen planus together.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Using a protocol with LH improves pregnancy rates in patients with low ovarian reserve.

Male sperm disorders significantly contribute to infertility.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Kinematic alignment in knee surgery often requires smaller femoral components than mechanical alignment.

Pre-surgical embolization and a two-stage resection improve outcomes for rare sacral tumors.

New treatments for severe alopecia areata show promise but lack standard approval.

Understanding different types of hair loss helps in accurate diagnosis and treatment.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

New treatments offer hope for better managing hidradenitis suppurativa.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Baricitinib reduces inflammation and improves cell health in premature aging cells.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.